Fidelity Investments
THRD

Fidelity Investments’s Third Harmonic Bio THRD Stock Holding History

Fidelity Investments’s Portfolio THRD Stock Details THRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-4,406
Closed -$23.9K – 5582
2025
Q2 		$23.9K Buy
4,406
+3,340
+313% +$16.7K ﹤0.01% 4225
2025
Q1 		$3.7K Sell
1,066
-2,535,474
-100% -$12.3M ﹤0.01% 4776
2024
Q4 		$26.1M Buy
2,536,540
+2,228,549
+724% +$27.8M ﹤0.01% 1630
2024
Q3 		$4.17M Buy
307,991
+304,250
+8,133% +$3.77M ﹤0.01% 2184
2024
Q2 		$48.6K Sell
3,741
-25
-0.7% -$309 ﹤0.01% 3639
2024
Q1 		$35.6K Buy
3,766
+46
+1% +$447 ﹤0.01% 3756
2023
Q4 		$40.8K Buy
3,720
+275
+8% +$2.18K ﹤0.01% 3606
2023
Q3 		$22K Buy
3,445
+693
+25% +$4.24K ﹤0.01% 3758
2023
Q2 		$13.2K Buy
2,752
+1,771
+181% +$8.43K ﹤0.01% 4041
2023
Q1 		$4.04K Buy
981
+872
+800% +$3.7K ﹤0.01% 4446
2022
Q4 		$469 Buy
+109
New +$1.82K ﹤0.01% 4756

Other funds holding THRD

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return
JC
JBF Capital Aspen, Colorado $676M AUM 24.74% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
AB
Amalgamated Bank New York $13.1B AUM 29.66% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
Optiver Holding
Optiver Holding Amsterdam, Netherlands $289B AUM 33.63% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Fidelity Investments's THRD Position: Q3 2025 in Review

Fidelity Investments sold out of Third Harmonic Bio (THRD) in Q3 2025, closing a stake of 4,406 shares — an estimated $23.9K sold.

Fidelity Investments first reported a position in THRD in Q4 2022 and held it in 11 quarters. The position peaked at $26.1M in Q4 2024. 18 funds tracked by Wall St. Rank hold THRD as of Q3 2025.

  • Fidelity Investments reported no remaining Third Harmonic Bio position as of Q3 2025 after selling out during the quarter.
  • Fidelity Investments sold 4,406 Third Harmonic Bio shares in Q3 2025, an estimated $23.9K.
  • Fidelity Investments first reported a position in Third Harmonic Bio in Q4 2022 and held it in 11 quarters.
  • Fidelity Investments's Third Harmonic Bio position peaked at $26.1M in Q4 2024.
  • 18 funds tracked by Wall St. Rank held Third Harmonic Bio as of Q3 2025.

Based on Fidelity Investments's 13F filing for Q3 2025, filed 13 Nov 2025.